Option Care Health (NASDAQ:OPCH) Downgraded to Neutral Rating by The Goldman Sachs Group

The Goldman Sachs Group cut shares of Option Care Health (NASDAQ:OPCH) from a buy rating to a neutral rating in a research note released on Monday, MarketBeat.com reports. The Goldman Sachs Group currently has $27.00 price objective on the stock, down from their previous price objective of $38.00.

Several other equities analysts have also issued reports on the company. Bank of America lowered Option Care Health from a “buy” rating to a “neutral” rating and decreased their target price for the stock from $43.00 to $29.00 in a research report on Wednesday, October 30th. Truist Financial reduced their price target on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research report on Friday, November 1st. JMP Securities upped their price objective on shares of Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research report on Monday, September 30th. Jefferies Financial Group cut Option Care Health from a “buy” rating to a “hold” rating and decreased their target price for the company from $38.00 to $26.00 in a research note on Thursday, October 31st. Finally, Barrington Research dropped their price target on Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research report on Thursday, October 31st. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat, Option Care Health has an average rating of “Moderate Buy” and a consensus target price of $30.83.

Option Care Health Stock Down 2.4 %

Shares of NASDAQ OPCH opened at $22.93 on Monday. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The firm has a market capitalization of $3.90 billion, a PE ratio of 19.27, a price-to-earnings-growth ratio of 2.33 and a beta of 1.32. The firm’s 50-day moving average is $29.98 and its 200-day moving average is $29.74. Option Care Health has a 1 year low of $22.25 and a 1 year high of $34.63.

Insider Transactions at Option Care Health

In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of the business’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the sale, the director now directly owns 21,339 shares of the company’s stock, valued at $663,429.51. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. In other news, CFO Michael H. Shapiro sold 23,217 shares of the stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the sale, the chief financial officer now owns 247,317 shares of the company’s stock, valued at approximately $7,654,461.15. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the firm’s stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the completion of the transaction, the director now directly owns 21,339 shares of the company’s stock, valued at $663,429.51. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.64% of the company’s stock.

Institutional Trading of Option Care Health

A number of large investors have recently added to or reduced their stakes in OPCH. Blue Trust Inc. increased its stake in shares of Option Care Health by 14.8% during the 2nd quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock worth $81,000 after purchasing an additional 377 shares during the last quarter. GAMMA Investing LLC grew its holdings in Option Care Health by 110.6% during the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after purchasing an additional 471 shares during the period. Lindenwold Advisors INC increased its position in Option Care Health by 5.4% during the third quarter. Lindenwold Advisors INC now owns 9,548 shares of the company’s stock worth $299,000 after buying an additional 489 shares during the last quarter. Trust Point Inc. raised its stake in Option Care Health by 2.6% in the third quarter. Trust Point Inc. now owns 24,124 shares of the company’s stock valued at $755,000 after buying an additional 622 shares during the period. Finally, Nisa Investment Advisors LLC lifted its position in shares of Option Care Health by 5.4% in the second quarter. Nisa Investment Advisors LLC now owns 13,581 shares of the company’s stock valued at $376,000 after buying an additional 690 shares during the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.